Search Results - "Vichinsky E"

A new method for augmenting short time series, with application to pain events in sickle cell disease.

Authors: Utkarsh, Kumar Shah, Nirmish R. Banerjee, Tanvi et al.

Source: PLoS Computational Biology. 6/21/2026, Vol. 22 Issue 6, p1-15. 15p.

SCDNet 1.0: Adaptive CNN Framework for Sickle Cell Disease Detection with OTSU Segmentation and Gaussian Filter.

Authors: Jain, Vanita Dubey, Arun Kumar Jain, Achin

Source: Journal of Intelligent & Fuzzy Systems; Jul2026, Vol. 50 Issue 7, p2086-2100, 15p

Prevalence of double heterozygotes of HbE and α-thal 1 (SEA) type in pregnancies and their partners that received antenatal care at Chiangrai Prachanukroh Hospital and reevaluated the cut-offs for differentiation.

Authors: Leckngam, Prapapun Wamontree, Phanida Chuaykarn, Tapanut

Source: PLoS ONE. 10/7/2025, Vol. 20 Issue 10, p1-13. 13p.

Factors Affecting Pain Control in Patients with Sickle Cell Disease at Mwananyamala and Muhimbili Hospitals in Dar es Salaam, Tanzania.

Authors: Igogo, Happiness Joseph Yonazi, Mbonea Mutagonda, Ritah F. et al.

Source: Journal of Clinical Medicine. Mar2026, Vol. 15 Issue 6, p2339. 12p.

Neurocognitive outcome in children with sickle cell disease after myeloimmunoablative conditioning and haploidentical hematopoietic stem cell transplantation: a non-randomized clinical trial.

Authors: Braniecki S Vichinsky E Walters MC et al.

Source: Frontiers in neurology [Front Neurol] 2024 May 22; Vol. 15, pp. 1263373. Date of Electronic Publication: 2024 May 22 (Print Publication: 2024).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101546899 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2295 (Print) Linking ISSN: 16642295 NLM ISO Abbreviation: Front Neurol Subsets: PubMed not MEDLINE

Derivation and Pluripotency Validation of Six iPSC Lines From Amniotic Fluid Carrying Intermediate α‐Thalassemia Genotypes (‐‐^3.7/α^SEA and ‐‐^4.2/α^SEA).

Authors: Chen, Qingyun Jiang, Xinxing Xue, Xinhuai et al.

Source: Stem Cells International. 6/3/2026, Vol. 2026, p1-10. 10p.

Senicapoc in Patients with Idiopathic Pulmonary Fibrosis or Other Progressive Fibrotic Interstitial Lung Diseases: Protocol for a Randomised, Double-Blind, Placebo-Controlled, Multicentre Phase II Trial.

Authors: Kølner-Augustson, Line Altraja, Alan Bendstrup, Elisabeth et al.

Source: Diagnostics (2075-4418). Jun2026, Vol. 16 Issue 11, p1649. 14p.

Challenges and opportunities in hydroxyurea access and adherence for sickle cell disease patients at Komfo Anokye Teaching Hospital: Insights from healthcare providers.

Authors: Mensah, Josephine Marfo, Afia Frimpomaa Asare Opare-Addo, Mercy Naa Aduele et al.

Source: PLoS ONE. 5/29/2026, Vol. 21 Issue 5, p1-14. 14p.

Feasibility of Intensive Chemotherapy in Hereditary Spherocytosis.

Authors: Valentina, Carrai Cristina, Giubbilei Manuel, Ciceri et al.

Source: Hematology Reports. Apr2025, Vol. 17 Issue 2, p11. 6p.

Use of the oxygen gradient ektacytometry in the dose titration of hydroxyurea therapy in children with sickle cell disease.

Authors: Houwing, Maite E. Bos, Jennifer van Wijk, Richard et al.

Source: International Journal of Laboratory Hematology. Apr2024, Vol. 46 Issue 2, p390-394. 5p.

Author index.

Source: International Journal of Laboratory Hematology. May2010 Supplement, Vol. 32, p176-180. 5p.

Non-Traumatic Fat Embolism Syndrome in Two HbSS Sickle Cell Disease Patients: A Case Series and Review.

Authors: Alzayer, Mohammed Amouri Abohelaika, Salah Alhaddad, Mousa et al.

Source: Journal of Blood Medicine. Oct2025, Vol. 16, p437-443. 7p.

Author index.

Source: Journal of Viral Hepatitis. Sep2012 Supplement, Vol. 19, p31-32. 4p.

Effect of dalcetrapib, voxelotor and their combination on red blood cell deformability and sickling in sickle cell disease.

Authors: Bordat, Claire Nader, Elie Connes, Philippe et al.

Source: Clinical Hemorheology & Microcirculation. Apr2025, Vol. 89 Issue 4, p335-339. 5p.

Transition from Pediatric to Adult Care in Patients with Transfusion-Dependent Beta-Thalassemia in France: A National Study Concerning a Rare Disease.

Authors: Szepetowski, Sarah Benoit, Audrey Berbis, Julie et al.

Source: Journal of Clinical Medicine. Mar2026, Vol. 15 Issue 6, p2203. 13p.

Sickle Cell Disease and Male Infertility: Pathophysiological Mechanisms, Clinical Manifestations, and Fertility Preservation Strategies—A Narrative Review.

Authors: Roidos, Christos Kaltsas, Aris Symeonidis, Evangelos N. et al.

Source: Life (2075-1729). Feb2026, Vol. 16 Issue 2, p192. 17p.

Investigating the effects of cannabinoids for the reduction of inflammation and sickle cell disease pain (CRISP); A protocol for a randomized double-blind placebo-controlled study.

Authors: Bellis, Jordan Monk, Lydia Jhawar, Ritika et al.

Source: PLoS ONE. 1/28/2026, Vol. 21 Issue 1, p1-9. 9p.

Transforming the treatment of Alpha-Thalassemia: a single-center retrospective study on hematopoietic stem cell transplantation in transfusion-dependent pediatric patients.

Authors: Huang L Wei Z Yang G et al.

Source: Annals of hematology [Ann Hematol] 2026 Mar 04; Vol. 105 (4). Date of Electronic Publication: 2026 Mar 04.

Publication Type: Journal Article

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE; In Process

The Efficacy and Safety of Deferasirox Monotherapy as a Second-Line Treatment in Transfusion-Dependent Thalassemia with Iron Overload.

Authors: Pongamnuaykrit, Manatchaya Tantiworawit, Adisak Niprapan, Piangrawee et al.

Source: Journal of Clinical Medicine. Sep2025, Vol. 14 Issue 17, p6212. 10p.

Misdiagnosis of α-Thalassemia Heterozygotes as Homozygotes Due to Base Mutations in the Primer Binding Region.

Authors: Ye, Lihua Li, Wei Wei, Guixi et al.

Source: Hemoglobin. Jul2025, Vol. 49 Issue 4, p237-243. 7p.